About Genicon
Genicon is a company based in Winter Park (United States) founded in 1998. Genicon has raised $7.6 million across 6 funding rounds from investors including Rand Capital, Advantage Capital and venVelo. The company has 6 employees as of September 30, 2012. Genicon operates in a competitive market with competitors including Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others.
- Headquarter Winter Park, United States
- Employees 6 as on 30 Sep, 2012
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Genicon, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$7.6 M (USD)
in 6 rounds
-
Latest Funding Round
$3.6 M (USD), Series B
Jul 20, 2017
-
Investors
Rand Capital
& 2 more
-
Employee Count
6
as on Sep 30, 2012
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Genicon
Unlock access to complete
Unlock access to complete
Funding Insights of Genicon
Genicon has successfully raised a total of $7.6M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $3.6 million completed in July 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Genicon
Genicon has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Rand Capital, Advantage Capital and venVelo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early & Growth stage VC Firm investing primarily in the US
|
Locked | Locked | Locked | |
|
Private equity investment firm
|
Locked | Locked | Locked | |
|
Early stage tech & life sciences focused VC firm investing in the US
|
Locked | Locked | Locked |
Investor details for Genicon
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genicon
Investment portfolio details for Genicon
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genicon
Detailed financials for Genicon
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genicon Comparisons
Peer comparison for Genicon
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genicon
Genicon operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Olympus, Eximis Surgical, SurgiQuest, New View Surgical and Xenocor, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Manufacturer of imaging and surgical products
|
|
| Locked | Locked | Locked |
Minimal invasive specimen removal tools
|
|
| Locked | Locked | Locked |
Products for minimally invasive surgery are developed and supplied.
|
|
| Locked | Locked | Locked |
Minimally invasive systems for laparoscopic surgery are developed.
|
|
| Locked | Locked | Locked |
Laparoscopic imaging systems for surgical applications are provided.
|
Detailed competitors of Genicon
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genicon
Complete news archive for Genicon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genicon
Genicon was founded in 1998 and raised its 1st funding round 16 years after it was founded.
Genicon is headquartered in Winter Park, United States. It is registered at Winter Park, Florida, United States.
Gary Haberland is the current CEO of Genicon.
Genicon is a funded company, having raised a total of $7.6M across 6 funding rounds to date.
As of Sep 30, 2012, the latest employee count at Genicon is 6.
Genicon was founded in 1998 and is based in Winter Park, United States. Surgical instruments for laparoscopic procedures are designed, produced, and distributed within the medical devices sector. Product offerings include trocar cannula systems, port systems, specimen retrieval devices, lavage tools, monopolar instruments, and ligation systems. Operations emphasize patented technologies for global distribution in surgical applications.
Genicon's top competitors include Olympus, New View Surgical and SurgiQuest.
Genicon has 3 investors. Key investors include Rand Capital, Advantage Capital, and venVelo.